A Study of Baricitinib and Omeprazole in Healthy Participants

NCT01925144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Baricitinib
DRUG: Omeprazole

Sponsor

Eli Lilly and Company